These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 23172878

  • 1. Post-chemoreduction cryptic optic nerve relapse in a patient with bilateral retinoblastoma.
    Shetye NG, Mataftsi A, Maeder P, Moulin AP, Gaillard MC, Balmer A, Popovic MB, Munier FL.
    Br J Ophthalmol; 2013 Feb; 97(2):233, 245-6. PubMed ID: 23172878
    [No Abstract] [Full Text] [Related]

  • 2. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [Abstract] [Full Text] [Related]

  • 3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 4. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [Abstract] [Full Text] [Related]

  • 5. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion.
    Chantada GL, Casco F, Fandiño AC, Galli S, Manzitti J, Scopinaro M, Schvartzman E, de Dávila MT.
    Ophthalmology; 2007 Nov; 114(11):2083-9. PubMed ID: 17459482
    [Abstract] [Full Text] [Related]

  • 6. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
    Kobylarz J, Piwowarczyk A, Romanowska-Dixon B, Balwierz W, Dłuzniewska A.
    Klin Oczna; 2006 Nov; 108(1-3):55-9. PubMed ID: 16883942
    [Abstract] [Full Text] [Related]

  • 7. What is the best treatment for retinoblastoma?
    Harbour JW.
    Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
    [No Abstract] [Full Text] [Related]

  • 8. Evolution in regression patterns following chemoreduction for retinoblastoma.
    Palamar M, Thangappan A, Shields CL.
    Arch Ophthalmol; 2011 Jun; 129(6):727-30. PubMed ID: 21670339
    [Abstract] [Full Text] [Related]

  • 9. [Current therapeutic management in retinoblastoma with invasion of the optic nerve--a case report].
    Gavriş M, Neamţu S, Gavriş S, Ghiţuică A.
    Oftalmologia; 1999 Jun; 46(1):69-71. PubMed ID: 10641091
    [Abstract] [Full Text] [Related]

  • 10. Preliminary experience in treatment of papillary and macular retinoblastoma: evaluation of local control and local complications after treatment with linear accelerator-based stereotactic radiotherapy with micromultileaf collimator as second-line or salvage treatment after chemotherapy.
    Pica A, Moeckli R, Balmer A, Beck-Popovic M, Chollet-Rivier M, Do HP, Weber DC, Munier FL.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):1380-6. PubMed ID: 20932660
    [Abstract] [Full Text] [Related]

  • 11. Various patterns of involvement of the optic disc in retinoblastoma.
    el Massri A.
    Metab Pediatr Syst Ophthalmol (1985); 1990 Dec 01; 13(1):15-9. PubMed ID: 2370831
    [Abstract] [Full Text] [Related]

  • 12. Cavitary changes in retinoblastoma: relationship to chemoresistance.
    Mashayekhi A, Shields CL, Eagle RC, Shields JA.
    Ophthalmology; 2005 Jun 01; 112(6):1145-50. PubMed ID: 15885779
    [Abstract] [Full Text] [Related]

  • 13. Magnetic resonance imaging for tumor restaging after chemotherapy in retinoblastoma with optic nerve invasion.
    Chawla B, Chaurasia S, Sharma S, Pattebahadur R, Hasan F, Seth R, Kashyap S, Sen S.
    Ophthalmic Genet; 2018 Oct 01; 39(5):584-588. PubMed ID: 30089224
    [Abstract] [Full Text] [Related]

  • 14. Choroidal Invasion in Retinoblastoma Treated with Intrarterial Chemotherapy.
    Abramson DH, Francis JH, Gobin YP.
    Ophthalmol Retina; 2018 Jan 01; 2(1):9. PubMed ID: 31047314
    [No Abstract] [Full Text] [Related]

  • 15. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
    Shields CL, Shields JA.
    Curr Opin Ophthalmol; 2010 May 01; 21(3):203-12. PubMed ID: 20224400
    [Abstract] [Full Text] [Related]

  • 16. Chemoreduction for retinoblastoma.
    Moll AC, Imhof SM, Schouten-van Meeteren AY, Boers M, van Leeuwen F, Hofman P.
    Arch Ophthalmol; 2003 Oct 01; 121(10):1513. PubMed ID: 14557204
    [No Abstract] [Full Text] [Related]

  • 17. Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients.
    King BA, Sahr N, Sykes A, Wilson MW, Brennan RC.
    Pediatr Blood Cancer; 2021 Apr 01; 68(4):e28882. PubMed ID: 33507604
    [Abstract] [Full Text] [Related]

  • 18. Overview: chemotherapy for retinoblastoma: an expanding area of clinical research.
    Schouten-Van Meeteren AY, Moll AC, Imhof SM, Veerman AJ.
    Med Pediatr Oncol; 2002 Jun 01; 38(6):428-38. PubMed ID: 11984806
    [No Abstract] [Full Text] [Related]

  • 19. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.
    Abramson DH, Frank CM, Dunkel IJ.
    Ophthalmology; 1999 Oct 01; 106(10):1947-50. PubMed ID: 10519590
    [Abstract] [Full Text] [Related]

  • 20. Retinoblastoma: evidence for postenucleation adjuvant chemotherapy.
    Kim JW.
    Int Ophthalmol Clin; 2015 Oct 01; 55(1):77-96. PubMed ID: 25436495
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.